Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells

被引:0
作者
Liquan Xue
Stephan W Morris
Carlos Orihuela
Elaine Tuomanen
Xiaoli Cui
Renren Wen
Demin Wang
机构
[1] St. Jude Children's Research Hospital,Department of Pathology
[2] St. Jude Children's Research Hospital,Department of Hematology/Oncology
[3] St. Jude Children's Research Hospital,Department of Infectious Diseases
[4] University of Tennessee,Department of Pediatrics
[5] College of Medicine,Department of Microbiology and Molecular Genetics
[6] Blood Research Institute,undefined
[7] The Blood Center of Southeastern Wisconsin,undefined
[8] Model Animal Research Center,undefined
[9] Nanjing University,undefined
[10] Medical College of Wisconsin,undefined
来源
Nature Immunology | 2003年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Bcl10 is an intracellular protein essential for nuclear factor (NF)-κB activation after lymphocyte antigen receptor stimulation. Using knockout mice, we show that absence of Bcl10 impeded conversion from transitional type 2 to mature follicular B cells and caused substantial decreases in marginal zone and B1 B cells. Bcl10-deficient B cells showed no excessive apoptosis. However, both Bcl10-deficient follicular and marginal zone B cells failed to proliferate normally, although Bcl10-deficient marginal zone B cells uniquely failed to activate NF-κB efficiently after stimulation with lipopolysaccharide. Bcl10-deficient marginal zone B cells did not capture antigens, and Bcl10-deficient (Bcl10−/−) mice failed to initiate humoral responses, leading to an inability to clear blood-borne bacteria. Thus, Bcl10 is essential for the development of all mature B cell subsets.
引用
收藏
页码:857 / 865
页数:8
相关论文
共 85 条
[1]  
Healy JI(1998)Positive versus negative signaling by lymphocyte antigen receptors Annu. Rev. Immunol. 16 645-670
[2]  
Goodnow CC(1999)B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals J. Exp. Med. 190 75-89
[3]  
Loder F(2002)Marginal-zone B cells Nat. Rev. Immunol. 2 323-335
[4]  
Martin F(1982)Migrant μ Eur. J. Immunol. 12 564-569
[5]  
Kearney JF(1998)δ Immunol. Today. 19 421-426
[6]  
Gray D(2000) and static μ Immunol. Rev. 175 9-22
[7]  
MacLennan IC(2000)δ Immunol. Rev. 175 70-79
[8]  
Bazin H(2001) B lymphocyte subsets Immunity. 14 617-629
[9]  
Khan M(2002)Human marginal-zone B cells Curr. Opin. Immunol. 14 241-249
[10]  
Spencer J(1999)B-1 cells: the lineage question revisited Cell 96 35-45